Correlation Between Day One and Ascendis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Ascendis Pharma AS, you can compare the effects of market volatilities on Day One and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Ascendis Pharma.

Diversification Opportunities for Day One and Ascendis Pharma

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Day and Ascendis is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Day One i.e., Day One and Ascendis Pharma go up and down completely randomly.

Pair Corralation between Day One and Ascendis Pharma

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Ascendis Pharma. In addition to that, Day One is 1.36 times more volatile than Ascendis Pharma AS. It trades about -0.1 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.01 per unit of volatility. If you would invest  12,769  in Ascendis Pharma AS on August 24, 2024 and sell it today you would earn a total of  1.00  from holding Ascendis Pharma AS or generate 0.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Ascendis Pharma AS

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Ascendis Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ascendis Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Day One and Ascendis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Ascendis Pharma

The main advantage of trading using opposite Day One and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.
The idea behind Day One Biopharmaceuticals and Ascendis Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope